- GLP1 drugs work but they likely need lifestyle modifications
- No convincing evidence GLP1 cause thyroid cancer in humans BUT contraindication if family history exist
- Stopping therapy usually results in weight gain
- Insurance coverage for weight loss is limited and variable
Semaglutide for type 2 diabetes max dose is 2.0 mg weekly Semaglutide for weight loss has a goal dose of 2.4 mg weeklyDiagnose steatotic liver disease with imaging and 1 metabolic risk factor (or biopsy)
- After diagnosis check FIB-4:
Low risk, continue to monitor with FIB-4 every 2-3yrs Intermediate risk, order VCTE and consider referral if >F1 High risk order a VCTE and referral (20% end with SLD)
- 2 FDA approved medications for liver fibrosis are not cheap, expect insurance push back